- Email:
Basic Neuroscience related Assay Services
Introduction
Neuroscience research has entered a golden age, with phenotypic drug discovery improving CNS drug success rates. We offer full-scale basic neuroscience assays, including calcium analysis, MEA measurement, high‑throughput screening, immunostaining, and neurotoxicity profiling to capture real‑time neuronal activity and support neuro‑drug discovery. Leveraging cutting‑edge technologies, we deliver high‑fidelity functional data, high‑resolution imaging, and standardized datasets to de‑risk CNS pipelines, bridge in vitro models to clinical translation, and provide robust evidence for drug development and IND applications.
Discover How We Can Help - Request a Consultation
Basic Neuroscience Related Assays
This series of assays supports fundamental neuroscience research by evaluating neuronal development, function, and pathophysiology using midbrain organoids. Services include immunofluorescence staining for neural and dopaminergic markers, gene expression analysis of key transcription factors, calcium imaging for neuronal activity, and electrophysiological detection to verify synaptic function and network maturation. These assays help characterize neural differentiation, identify disease-related phenotypes, and explore molecular mechanisms in a physiologically relevant 3D model.
Workflow
To initiate the service, clients typically provide the required starting materials, such as:
- Specific Cell Lines: iPSC-derived neurons, primary rodent neurons, or immortalized neural progenitor cells.
- Test Compounds: Small molecules, antibodies, or viral vectors (AAV/Lentivirus) with defined concentration ranges.
- Project Specifications: Desired readouts (e.g., peak amplitude, burst frequency) and disease-specific biomarkers.
What We Can Offer
At Creative Biolabs, we go beyond standard testing. We provide a One-Stop Neuro-Analytical Service—from initial pilot-scale screens to large-scale industrial validation—tailored precisely to your molecule's unique mechanism.
One-stop functional assay service
from laboratory-scale proof-of-concept to pilot-scale drug screening.
Highly customized service modules
allowing for tailored experimental designs that match your specific therapeutic targets and disease models.
Large-capacity screening infrastructure
featuring automated liquid handling and high-throughput imaging capable of processing thousands of data points simultaneously.
Well-established quality system
incorporating Quality-by-Design (QbD) and process analytical techniques (PAT) to ensure consistent data integrity across all batches.
Rigorous aseptic validation and cell bank characterization
for iPSC-derived and primary neural cultures to guarantee phenotypic stability.
Optimization of culture conditions and media formulations
to maximize the physiological relevance and longevity of your neural models.
High-standard quality control tools
and Hazard Analysis Critical Control Point (HACCP) principles are applied to every step of the neuronal activity monitoring process.
Advanced genomic and proteomic integration
to facilitate the evaluation of target engagement alongside phenotypic outcomes.
Experience the Creative Biolabs Advantage - Get a Quote Today
Customer Reviews
FAQs
Q1: How do your assays compare to traditional animal models in terms of predictability?
A: Our human iPSC-derived neural assays often provide higher translational fidelity for human-specific targets, as they avoid the interspecific metabolic differences often found in rodent models.
Q2: Can you accommodate high-throughput screening for libraries exceeding 10,000 compounds?
A: Yes, our automated HCS and phenotypic screening platforms are designed for scale, ensuring rapid processing with high reproducibility across large-scale studies.
Q3: What precautions are taken to ensure the stability of primary neuronal cultures?
A: We utilize specialized media and environmental controls (CO2/Temperature) during all assay phases, with rigorous QC checks for cell density and spontaneous activity before compound treatment.
Q4: Is it possible to combine MEA with other imaging modalities?
A: Yes. We offer integrated workflows where electrical activity can be correlated with end-point immunostaining or live-cell imaging for a full-scale functional-structural analysis.
Q5: What is the primary advantage of Sparse Labeling for my project?
A: If you are studying axonal guidance or dendritic branching in a dense environment, sparse labeling allows you to isolate and trace individual cells that would otherwise be obscured, providing clearer morphological data.
Creative Biolabs provides a specialized ecosystem for Neuroscience R&D, ranging from foundational assays to advanced phenotypic screening. We are committed to delivering high-quality, reproducible data that accelerates the development of life-changing neurological therapies.
Contact Our Team for More Information and to Discuss Your Project
For Research Use Only. Not For Clinical Use.